Plasma cotinine levels and pancreatic cancer in the EPIC cohort study.

Authors:

Leenders M, Chuang SC, Dahm CC, Overvad K, Ueland PM, Midttun O, Vollset SE, Tjønneland A, Halkjaer J, Jenab M, Clavel-Chapelon F, Boutron-Ruault MC, Kaaks R, Canzian F, Boeing H, Weikert C, Trichopoulou A, Bamia C, Naska A, Palli D, Pala V, Mattiello A, Tumino R, Sacerdote C, Duijnhoven FJ, Peeters PH, Gils CH, Lund E, Rodriguez L, Duell EJ, Pérez MJ, Molina-Montes E, Castaño JM, Barricarte A, Larrañaga N, Johansen D, Lindkvist B, Sund M, Ye W, Khaw KT, Wareham NJ, Michaud DS, Riboli E, Xun WW, Allen NE, Crowe FL, Bueno-de-Mesquita HB, Vineis P.

Journal:

Int J Cancer 2012; 131: 997-1002. (IF 6.198)

Year:
2012
Kind:
Articoli

This site uses technical, analytics and third-party cookies. By continuing to browse, you accept the use of cookies.